DNTH
DIANTHUS (DNTH)
NASDAQ
$86.88-$0.49 (-0.56%)
Price as of Jun 23, 2026 3:13 PM EDT
  • $4.8B
    Market Cap
  • 407.97%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
FMR LLC
18.61%
7.8M
+1.3M (+17.20%)
Mar 31, 2026
BLACKROCK, INC.
7.61%
3.2M
+1.3M (+39.69%)
Mar 31, 2026
RA CAPITAL MANAGEMENT, L.P.
6.26%
2.6M
+1.0M (+38.29%)
Mar 31, 2026
WELLINGTON MANAGEMENT GROUP LLP
6.22%
2.6M
+92,593 (+3.57%)
Mar 31, 2026
FAIRMOUNT FUNDS MANAGEMENT LLC
6.08%
2.5M
+400,000 (+15.77%)
Mar 31, 2026
DEEP TRACK CAPITAL, LP
5.35%
2.2M
-124,554 (-5.58%)
Jun 30, 2025
AVIDITY PARTNERS MANAGEMENT LP
5.04%
2.1M
0 (0.00%)
Mar 31, 2026

Current Ownership Distribution

  • Institutions269.3M (81.49%)
  • Mutual Funds54.5M (16.48%)
  • Insiders6.7M (2.03%)
  • Other0 (0.00%)

Insider Transactions

  • 2.03% (6.7M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 4
    Number of InsiderSelling (last 12 months)
  • $54.3M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Veness Adam M
SVP, General Counsel and Sec.
Exempt
Jun 17, 2026
$0.00
30,000
$0.00
80,000
Veness Adam M
SVP, General Counsel and Sec.
Exempt
Jun 17, 2026
$536,400.00
30,000
$17.88
30,000
Veness Adam M
SVP, General Counsel and Sec.
Sell
Jun 17, 2026
$1.3M
16,771
$80.34
13,229
Veness Adam M
SVP, General Counsel and Sec.
Sell
Jun 17, 2026
$1.1M
13,229
$81.38
0
Savitz Ryan
EVP, CFO & CBO
Exempt
Apr 09, 2026
$0.00
8,224
$0.00
71,776
Savitz Ryan
EVP, CFO & CBO
Exempt
Apr 09, 2026
$147,045.12
8,224
$17.88
8,224
Savitz Ryan
EVP, CFO & CBO
Sell
Apr 09, 2026
$738,844.16
8,224
$89.84
0
Soteropoulos Paula
Exempt
Mar 31, 2026
$0.00
599
$0.00
599
Savitz Ryan
EVP, CFO & CBO
Exempt
Mar 31, 2026
$0.00
74,367
$0.00
10,399
Soteropoulos Paula
Exempt
Mar 31, 2026
$5,055.56
599
$8.44
599
Savitz Ryan
EVP, CFO & CBO
Exempt
Mar 31, 2026
$0.00
40,000
$0.00
80,000
Soteropoulos Paula
Sell
Mar 31, 2026
$47,985.89
599
$80.11
0
Savitz Ryan
EVP, CFO & CBO
Exempt
Mar 31, 2026
$627,657.48
74,367
$8.44
74,367
Savitz Ryan
EVP, CFO & CBO
Exempt
Mar 31, 2026
$715,200.00
40,000
$17.88
114,367
Savitz Ryan
EVP, CFO & CBO
Sell
Mar 31, 2026
$108,878.70
1,390
$78.33
112,977
Savitz Ryan
EVP, CFO & CBO
Sell
Mar 31, 2026
$1.7M
21,825
$78.86
91,152
Savitz Ryan
EVP, CFO & CBO
Sell
Mar 31, 2026
$119,171.25
1,485
$80.25
89,667
Savitz Ryan
EVP, CFO & CBO
Sell
Mar 31, 2026
$65,088.00
800
$81.36
88,867
Savitz Ryan
EVP, CFO & CBO
Sell
Mar 31, 2026
$195,999.44
2,366
$82.84
86,501
Savitz Ryan
EVP, CFO & CBO
Sell
Mar 31, 2026
$5.0M
59,800
$83.90
26,701
Savitz Ryan
EVP, CFO & CBO
Sell
Mar 31, 2026
$1.6M
19,469
$84.57
7,232
Savitz Ryan
EVP, CFO & CBO
Sell
Mar 31, 2026
$618,625.28
7,232
$85.54
0
Soteropoulos Paula
Exempt
Mar 24, 2026
$0.00
27,594
$0.00
1,198
Soteropoulos Paula
Exempt
Mar 24, 2026
$232,893.36
27,594
$8.44
27,594
Soteropoulos Paula
Sell
Mar 24, 2026
$2.2M
27,594
$78.05
0
Garcia Marino
CEO AND PRESIDENT
Exempt
Mar 16, 2026
$0.00
59,700
$0.00
41
Garcia Marino
CEO AND PRESIDENT
Exempt
Mar 16, 2026
$0.00
5,592
$0.00
269,408
Garcia Marino
CEO AND PRESIDENT
Exempt
Mar 16, 2026
$399,990.00
59,700
$6.70
59,700
Garcia Marino
CEO AND PRESIDENT
Exempt
Mar 16, 2026
$99,984.96
5,592
$17.88
65,292
Randhawa Simrat
EVP, Head of R&D
Exempt
Mar 12, 2026
$0.00
7,998
$0.00
3,998